Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC)

Author:

Waksman Ron1ORCID,Pahuja Mohit2ORCID,van Diepen Sean3ORCID,Proudfoot Alastair G.45ORCID,Morrow David6ORCID,Spitzer Ernest78ORCID,Nichol Graham9ORCID,Weisfeldt Myron L.10,Moscucci Mauro11ORCID,Lawler Patrick R.121314ORCID,Mebazaa Alexandre15ORCID,Fan Eddy16ORCID,Dickert Neal W.17ORCID,Samsky Marc18ORCID,Kormos Robert19ORCID,Piña Ileana L.20ORCID,Zuckerman Bram11,Farb Andrew11,Sapirstein John S.11,Simonton Charles21,West Nick E.J.22ORCID,Damluji Abdulla A.23ORCID,Gilchrist Ian C.24ORCID,Zeymer Uwe25ORCID,Thiele Holger2627ORCID,Cutlip Donald E.28ORCID,Krucoff Mitchell29,Abraham William T.30ORCID

Affiliation:

1. Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC (R.W.).

2. Division of Cardiology, University of Oklahoma Health Sciences Center, Oklahoma City (M.P.).

3. Department of Critical Care Medicine and Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Canada (S.v.D.).

4. Department of Perioperative Medicine, Barts Heart Centre, London, UK (A.G.P.).

5. Department of Cardiac Anesthesiology and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Germany (A.G.P.).

6. Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (D.M.).

7. Cardialysis, Rotterdam, The Netherlands (E.S.).

8. Cardiology Department, Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands (E.S.).

9. University of Washington-Harborview Center for Prehospital Emergency Care, University of Washington Harborview Center, Seattle (G.N.).

10. Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD (M.L.W.).

11. Office of Cardiovascular Devices, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD (M.M., B.Z., A.F., J.S.S.).

12. Peter Munk Cardiac Centre, Toronto General Hospital Research Institute, Canada (P.R.L.).

13. McGill University Health Centre, Montreal, Canada (P.R.L.).

14. Interdepartmental Division of Critical Care Medicine, University of Toronto, Canada (P.R.L.).

15. Université Paris Cité, Department of Anesthesiology and Critical Care Medicine, Hôpital Lariboisière, France (A.M.).

16. Interdepartmental Division of Critical Care Medicine, University of Toronto, Canada (E.F.).

17. Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, GA (N.W.D.).

18. Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT (M.S.).

19. Global Medical Affairs Heart Failure, Abbott Laboratories, Austin, TX (R.K.).

20. Division of Cardiology, Thomas Jefferson University, Philadelphia, PA (I.L.P.)

21. Abiomed, Danvers, MA (C.S.).

22. Abbott Vascular, Santa Clara, CA (N.E.J.W.).

23. Inova Center of Outcomes Research, Inova Heart and Vascular Institute, Falls Church, VA (A.A.D.).

24. Department of Interventional Cardiology/Heart and Vascular Institute, Penn State Health/Hershey Medical Center (I.C.G.).

25. Institut für Herzinfarktforschung Ludwigshafen, Germany (U.Z.).

26. Heart Center Leipzig at University of Leipzig, Germany (H.T.).

27. Leipzig Heart Science, Germany (H.T.).

28. Beth Israel Deaconess Medical Center and Harvard Medical School, Boston MA (D.E.C.).

29. Department of Medicine, Duke University School of Medicine, Durham, NC (M.K.).

30. Division of Cardiovascular Medicine and the Davis Heart and Lung Research Institute, The Ohio State University College of Medicine/Ohio State University Wexner Medical Center, Columbus (W.T.A.).

Abstract

The Shock Academic Research Consortium is a multi-stakeholder group, including representatives from the US Food and Drug Administration and other government agencies, industry, and payers, convened to develop pragmatic consensus definitions useful for the evaluation of clinical trials enrolling patients with cardiogenic shock, including trials evaluating mechanical circulatory support devices. Several in-person and virtual meetings were convened between 2020 and 2022 to discuss the need for developing the standardized definitions required for evaluation of mechanical circulatory support devices in clinical trials for cardiogenic shock patients. The expert panel identified key concepts and topics by performing literature reviews, including previous clinical trials, while recognizing current challenges and the need to advance evidence-based practice and statistical analysis to support future clinical trials. For each category, a lead (primary) author was assigned to perform a literature search and draft a proposed definition, which was presented to the subgroup. These definitions were further modified after feedback from the expert panel meetings until a consensus was reached. This manuscript summarizes the expert panel recommendations focused on outcome definitions, including efficacy and safety.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3